4D Molecular Therapeutics Ratios (2019-2025) | FDMT

Ratios Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -371.91%-416.60%-105.27%2,089.87%-815.25%-52.05%-1,627.09%-27,256.52%-2,156.85%-17,337.04%-5,140.00%-2,195.83%-9,618.46%-12,394.98%-49.98%169,852.63%-115,682.14%-698,160.00%-1,461,400.00%-4,965,000.00%-343,135.71%-363,980.00%-63,172.22%
EBIT Margin -375.59%-416.98%-105.32%2,090.28%-815.60%-52.10%-1,658.93%-26,917.39%-2,165.05%-17,546.91%-5,299.00%-2,303.13%-10,102.68%-13,446.03%-69.16%192,905.26%-136,200.00%-849,120.00%-1,704,400.00%-5,611,700.00%-383,007.14%-396,373.33%-67,983.33%
EBITDA Margin -375.59%-416.98%-105.32%2,090.28%-815.60%-52.10%-1,658.93%-26,917.39%-2,165.05%-17,546.91%-5,299.00%-2,303.13%-10,102.68%-13,446.03%-69.16%192,905.26%-136,200.00%-849,120.00%-1,704,400.00%-5,611,700.00%-383,007.14%-396,373.33%-67,983.33%
Operating Margin -375.59%-416.98%-105.32%2,090.28%-815.60%-52.10%-1,658.93%-26,917.39%-2,165.05%-17,546.91%-5,299.00%-2,303.13%-10,102.68%-13,446.03%-69.16%192,905.26%-136,200.00%-849,120.00%-1,704,400.00%-5,611,700.00%-383,007.14%-396,373.33%-67,983.33%
Net Margin -372.28%-417.09%-105.55%2,103.07%-820.30%-52.05%-1,628.04%-27,264.13%-2,160.62%-17,337.04%-5,138.20%-2,195.59%-9,624.83%-12,391.63%-50.76%169,910.53%-115,717.86%-699,060.00%-1,461,433.33%-4,967,100.00%-342,657.14%-364,386.67%-63,195.56%
FCF Margin -412.76%-173.11%-175.74%1,841.04%-800.70%-116.20%-1,343.78%-29,273.91%-2,458.00%-13,561.73%-4,596.20%-1,869.05%-9,704.03%-9,569.04%-7.80%132,626.32%-106,421.43%-611,840.00%-1,038,966.67%-4,681,200.00%-345,635.71%-289,620.00%-51,563.33%
Efficiency
Assets Average 279.22M262.52M247.78M297.05M339.21M313.93M291.55M271.00M252.93M298.26M357.06M350.75M484.89M625.00M612.07M582.21M538.06M494.68M448.81M
Equity Average 249.41M241.54M232.39M271.62M307.58M284.29M261.98M241.39M224.97M271.88M327.54M318.88M454.19M594.45M570.64M531.78M490.16M445.31M394.94M
Invested Capital -72.97M256.39M242.43M240.65M224.13M319.11M296.06M272.52M251.44M231.34M218.61M325.14M329.93M307.83M600.56M588.34M552.95M510.61M469.72M420.89M368.98M
Asset Utilization Ratio 0.040.090.070.060.050.010.010.010.010.010.060.060.040.030.000.000.000.000.00
Leverage & Solvency
Equity Ratio -1.250.890.900.940.930.900.910.900.900.880.900.920.910.910.950.950.920.910.910.890.87
Valuation
Enterprise Value -49.65M711.18M446.76M400.30M566.20M457.35M251.28M-15.64M32.64M505.88M370.84M290.67M215.67M577.96M1,060.02M543.31M59.90M-167.39M-171.88M-121.36M100.78M
Market Capitalization 987.91M706.62M644.04M727.87M705.13M487.43M225.45M260.35M719.43M571.30M601.02M535.33M866.19M1,585.93M1,085.25M561.79M257.49M149.56M171.86M405.84M
Return Ratios
Return on Sales -4.15%-4.94%-2.26%-3.92%-3.95%-4.70%-35.82%-53.30%-34.35%-49.76%-48.76%-4.36%-4.86%-5.10%-5.42%
Return on Capital Employed -0.23%-0.21%-0.28%-0.25%-0.25%-0.34%-0.38%-0.43%-0.47%-0.41%-0.31%-0.34%-0.26%-0.22%-0.29%-0.34%-0.40%-0.48%-0.56%
Return on Assets -0.21%-0.20%-0.27%-0.24%-0.24%-0.32%-0.36%-0.40%-0.43%-0.37%-0.27%-0.29%-0.22%-0.18%-0.23%-0.28%-0.33%-0.40%-0.47%
Return on Equity -0.24%-0.22%-0.29%-0.26%-0.26%-0.36%-0.40%-0.45%-0.49%-0.41%-0.29%-0.32%-0.23%-0.18%-0.25%-0.30%-0.36%-0.44%-0.53%